|
Developmental Studies Hybridoma Bank
anti versican mouse monoclonal antibody Anti Versican Mouse Monoclonal Antibody, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dshb+%E2%80%A2+12c5/pm12962636-208-1-14?v=Developmental+Studies+Hybridoma+Bank Average 93 stars, based on 1 article reviews
anti versican mouse monoclonal antibody - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
versican ![]() Versican, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dshb+%E2%80%A2+12c5/pmc01851142-142-77-109?v=Santa+Cruz+Biotechnology Average 93 stars, based on 1 article reviews
versican - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal:
Article Title: Identification of Vascular Lineage-Specific Genes by Transcriptional Profiling of Isolated Blood Vascular and Lymphatic Endothelial Cells
doi:
Figure Lengend Snippet: Blood vessel-specific expression of VEGFR-1/Flt1, N-cadherin, versican, and endoglin in normal human skin. Differential immunostains reveal mutually exclusive expression of LYVE-1 (red) on lymphatic vessels and of VEGFR-1/Flt-1 (A), N-cadherin (E), versican (I), and endoglin (M) on cutaneous blood vessels (green). Nuclear Hoechst counterstain (blue) was used to depict skin morphology. Double immunostains for the pan-endothelial marker CD31 (red) and selected blood vascular markers (green) demonstrate that only a fraction of all vessels also express VEGFR-1/Flt1 (B–D), N-cadherin (F–H), versican (J–L), or endoglin (N–P). Scale bar, 50 μm.
Article Snippet: 25 Immunostains Immunofluorescence stainings were performed on 6-μm cryostat sections of neonatal human foreskin or on 10-μm sections of mouse embryos as previously described, 22,26 using antibodies to Prox1, 22 murine or human LYVE-1 (kindly provided by Dr. D. Jackson, John Radcliffe Hospital, Oxford, UK 20 ), human CD34 and CD31 (BD Pharmingen), mouse VEGFR-1 (MF1; kindly provided by Dr. DJ Hicklin, Imclone Systems, New York, NY) and human VEGFR-1/Flt-1 (Sigma), N-cadherin (Transduction Laboratories, San Diego, CA),
Techniques: Expressing, Marker